Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

Manufacturer
Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
Effective date
2023-02-28
Label type
HUMAN OTC DRUG LABEL
Version
10
Source
legacy-cache
Hydrated at
2026-08-01 21:30:47

Label at a glance#

ProductFallback Solo
Active ingredientLEVONORGESTREL
Label structure13 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Levonorgestrel USP 1.5 mg

Purpose

OTC - PURPOSE SECTION

Emergency contraceptive

Indications

INDICATIONS & USAGE SECTION

Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control).

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you have ever had an allergic reaction to levonorgestrel.

Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs

Do not use

  • if you are already pregnant (because it will not work)
  • for regular birth control

Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel.

When using this product you may have

  • menstrual changes
  • nausea
  • lower stomach (abdominal) pain
  • tiredness
  • headache
  • dizziness
  • breast pain
  • vomiting

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

This package is not child resistant. Keep this and all medication out of the reach of children.

In case of overdose, get medical help or contact a Poison Control center right away.

SPL UNCLASSIFIED SECTION

Directions

  • take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.
  • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose.

Other Information

  • read the instructions, warnings and enclosed product leaflet before use .
  • this product works mainly by preventing ovulation (egg release). It may also prevent fertilization of a released egg (joining of sperm and egg) or attachment of a fertilized egg to the uterus (implantation).
  • tablet is enclosed in wallet seal. Do not use if the wallet seal is broken .
  • store at 25°C (77°C); excursions permitted to 15 to 30°C (59 to 86°C) [see USP Controlled Room temperature].

Inactive Ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and povidone.

SPL UNCLASSIFIED SECTION

Questions or comments?

For more information call 1800-399-2561 or visit our website at www.birthcontrolhealth.com.

SPL UNCLASSIFIED SECTION

Fallback Solo™

(levonorgestrel) Tablet, 1.5 mg

Emergency Contraceptive

One Tablet. One Dose.

What You Need to Know

SPL UNCLASSIFIED SECTION

What is Fallback Solo™?

Fallback Solo™ is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.

What Fallback Solo is not.

Fallback Solo will not work if you are already pregnant and will not affect an existing pregnancy. Fallback Solo will not protect you from HIV infection (the virus that causes AIDS) and other sexually transmitted diseases (STDs).

When should I use Fallback Solo?

DOSAGE & ADMINISTRATION SECTION

The sooner you take emergency contraception, the better it works. You should use Fallback Solo within 72 hours (3 days) after you have had unprotected sex.

Fallback Solo is a backup or emergency method of birth control you can use when:

  • your regular birth control was used incorrectly or failed
  • you did not use any birth control method

SPL UNCLASSIFIED SECTION

When not to use Fallback Solo?

Fallback Solo should not be used:

  • as a regular birth control method, because it's not as effective as regular birth control.
  • if you are already pregnant, because it will not work.
  • if you are allergic to levonorgestrel or any other ingredients in Fallback Solo.

When should I talk to a doctor or pharmacist?

Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of Fallback Solo and increase your chance of becoming pregnant. Your doctor may prescribe another form of emergency contraception that may not be affected by these medications.

How does Fallback Solo work?

Fallback Solo works before release of an egg from the ovary. As a result, Fallback Solo usually stops or delays the release of an egg from the ovary. Fallback Solo is one tablet that contains a higher dose of levonorgestrel than birth control pills and works in a similar way to prevent pregnancy.

How can I get the best results from Fallback Solo?

You have 72 hours (3 days) to try to prevent pregnancy after birth control failure or unprotected sex. The sooner you take Fallback Solo, the better it works.

How effective is Fallback Solo?

If Fallback Solo is taken as directed, it can significantly decrease the chance that you will get pregnant. About 7 out of every 8 women who would have gotten pregnant will not become pregnant.

How will I know Fallback Solo worked?

You will know Fallback Solo has been effective when you get your next period, which should come at the expected time, or within a week of the expected time. If your period is delayed beyond 1 week, it is possible you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional.

Will I experience any side effects?

  •   some women may have changes in their period, such as a period that is heavier or lighter or a period that is early or late. If your period is more than a week late, you may be pregnant.
  •   If you have severe abdominal pain, you may have an ectopic pregnancy, and should get immediate medical attention.
  •   when used as directed, Fallback Solo is safe and effective. Side effects may include changes in your period, nausea, lower stomach (abdominal) pain, tiredness, headache, dizziness, and breast tenderness.
  •   if you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose.

What if I still have questions about Fallback Solo?

If you have questions or need more information, call our toll-free number, 1800-399-2561 or visit our website at www.birthcontrolhealth.com.

Other Information

Keep this and all medication out of reach of children:

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Do not use if the wallet seal is opened.

Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].

Active Ingredient: levonorgestrel 1.5 mg

Inactive Ingredients: colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and povidone.

Fallback Solo™ is a trademark of Lupin Pharmaceuticals, Inc.

Distributed By:

Lupin Pharmaceuticals, Inc.

Baltimore, Maryland 21202

United States

Manufactured by:

Lupin Limited

Pithampur (M.P.) - 454 775

INDIA

Revised: May, 2023                                                                            ID#: 273480

If you are sexually active, you should see a healthcare provider for routine checkups. Your healthcare provider will talk to you about and, if necessary, test you for sexually transmitted diseases, teach you about effective methods of routine birth control, and answer any other questions you may have.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

NDC 68180-853-11

Wallet Label: 1 Tablet

Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-11 Wallet Label: 1 Tablet
Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-11 Wallet Label: 1 Tablet

Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

NDC 68180-853-13

Carton Label: 1 Tablet

Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-13 Carton Label: 1 Tablet
Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-13 Carton Label: 1 Tablet

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68180-853-11EA - Each68180-853a7e71e8c-c6de-4a8c-8c63-32f0a4264d5812014-10-03
68180-853-13EA - Each68180-85398033c05-e1c1-48a6-8eea-4c2b868e5a7a12014-10-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LEVONORGESTRELACTIVE INGREDIENT5W7SIA7YZW3
LEVONORGESTRELACTIVE MOIETY5W7SIA7YZW3
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU43
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5X3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I303
POVIDONE K30INACTIVE INGREDIENTU725QWY32X3
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJ3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68180-85368180-853-11, 68180-853-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 188 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPOWDER, FOR SUSPENSION / ORALNAExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XPOWDER, FOR SUSPENSION / ORAL257 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CREAM / TOPICALNAExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJCAPSULE, COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, COATED / ORAL184 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION / ORAL64 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, COATED / ORAL176 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4INSERT / VAGINAL8 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, DELAYED RELEASE PARTICLES / ORAL170 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION / ORAL200 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4DROPS / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJPOWDER, FOR SUSPENSION / ORAL34 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / BUCCAL3 mgExact identifier — unii candidate
49 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJCAPSULE / ORAL5785 mgExact identifier — unii candidate
22 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINSERT / VAGINAL2282 mgExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, COATED / ORAL1301 mgExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XTABLET, CHEWABLE, EXTENDED RELEASE / ORAL12 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, DELAYED RELEASE / ORAL144 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL47 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET / SUBLINGUAL409 mgExact identifier — unii candidate
22 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS107 mgExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XTABLET, FOR SUSPENSION / ORAL462 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, DELAYED RELEASE / ORAL713 mgExact identifier — unii candidate
22 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XFILM / SUBLINGUAL7 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30WAFER / ORAL66 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XGRANULE, FOR SOLUTION / ORAL1691.8 mg/120mlExact identifier — unii candidate
38 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XINSERT / VAGINAL147 mgExact identifier — unii candidate
40 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJSUSPENSION, EXTENDED RELEASE / ORAL113 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FILM COATED, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION / INTRAMUSCULAR150 mgExact identifier — unii candidate
38 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION / ORAL400 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FOR SUSPENSION / ORAL131 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, EXTENDED RELEASE / ORAL5364 mgExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / SUBLINGUAL505 mgExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XTABLET / BUCCAL1 mgExact identifier — unii candidate
40 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii candidate
49 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XFILM, EXTENDED RELEASE / TRANSDERMAL16 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30IMPLANT / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJSUSPENSION/ DROPS / ORAL90 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED PELLETS / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUPPOSITORY / RECTAL14 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SYSTEM / INTRAVITREAL0.02 mgExact identifier — unii candidate
39 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XGRANULE / ORAL202 mgExact identifier — unii candidate
40 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FILM COATED / ORAL968 mgExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XLOZENGE / ORAL700 mgExact identifier — unii candidate
40 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION / SUBCUTANEOUS98 mgExact identifier — unii candidate
38 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INSERT / VAGINAL69 mgExact identifier — unii candidate
39 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XSOLUTION/ DROPS / OPHTHALMIC4 mgExact identifier — unii candidate
40 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TAMPON / VAGINALNAExact identifier — unii candidate
49 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FOR SUSPENSION / ORAL2794 mgExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS9.5 %w/vExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPELLET / ORAL640 mgExact identifier — unii candidate
38 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A201446-001FALLBACK SOLOLEVONORGESTREL1.5MGTABLET / ORAL2014-06-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19c2088c7a36db…
2026-09-14 22:38:342026-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1984e616aacf4f…
2026-08-18 06:07:402026-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1987673890dc5c…
2021-03-12 10:30 UTC2021-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193f01610625f2…
2019-09-15 20:21 UTC2019-09A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19b00525d2431f…
2019-07-19 19:46 UTC2019-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193f0d92c62455…
2023-05-13 08:27 UTC2023-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19053a50430f4f…
2023-01-26 05:58 UTC2023-01A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ce23e28b-2919-44d6-933f-09971f44b01938c26cb9-052e-426f-9916-c13e7a5e62d02023-12-20WarningsExact identifier
spl set id: 38c26cb9-052e-426f-9916-c13e7a5e62d0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.